跳至主要内容
临床试验/PACTR202109892575291
PACTR202109892575291已完成3 期

The Effect of Intravenous Infusion of Dexmedetomidine versus Lidocaine as an Analgesic Adjuvant to Balanced General Anesthesia and Enhanced Recovery After Abdominal Surgery

未提供0 个研究点目标入组 140 人开始时间: 2021年9月21日最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
140

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • Patients (age 21-55 years)
  • With body mass index (BMI) 18-25 Kg/m2.
  • ASA 1 and ASA 2 patients
  • Adequate cognitive state (able to understand and collaborate).
  • Patients that will undergo elective open abdominal surgery

排除标准

  • Hypersensitivity to any of the used drugs
  • Pregnancy and lactating mothers
  • Chronic pain requiring daily use of opioid medication or chronic alcohol abuser
  • Sleep apnea syndrome.
  • Bradycardia (heart rate of fewer than 50 beats per min at rest) or patients on beta-blockers or alpha 2 agonists.
  • Epilepsy or chronic daily use of psychiatric medication
  • Patients received any other regional anesthesia technique (epidural, transverse abdominis plane (TAP) and Plexus block)
  • Re-exploration cases

研究者

发起方
未提供

相似试验